Inventor · disambiguated record
Kenta Haraya
Also filed as: HARAYA KENTA
6 granted patents·11 pending applications·75 citations·filing 2012–2023
83Inventor score
Top patents by PatentIndex Score
17 records- 0196US11718678B2Method for altering plasma retention and immunogenicity of antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 8, 2023·7 cites·16 claims
- 0294US10618965B2Method for altering plasma retention and immunogenicity of antigen-binding moleculeIGAWA TOMOYUKI·Filed 2012·Granted Apr 14, 2020·32 cites·33 claims
- 0394US10519229B2Nucleic acids encoding IL-8 antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 31, 2019·22 cites·33 claims
- 0493US11180548B2Methods of neutralizing IL-8 biological activityCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 23, 2021·6 cites·11 claims
- 0585US10556949B2Antigen-binding molecule inducing immune response to target antigenCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Granted Feb 11, 2020·8 cites·26 claims
- 0673US2022389118A1Antigen-binding molecule for promoting elimination of antigensCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0768US2023140797A1ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIBCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0868US2023250162A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0962US12371485B2Antigen-binding molecule inducing immune response to target antigenCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jul 29, 2025·0 cites·22 claims
- 1061US2023257470A1Method for altering plasma retention and immunogenicity of antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1158US2019112393A1Antigen-binding molecule for promoting elimination of antigensCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1256US2014335089A1Antigen-binding molecule for promoting elimination of antigensCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Application pending·0 cites
- 1356US2020407432A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1449US2022017585A1Cxcr3 ligandCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1549US2016046693A1Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIBCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1646US2019367599A1Pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related diseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1740US2021198347A1Anti-complement component antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenta Haraya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →